{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:03:57Z","timestamp":1792047837865,"version":"4.4.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Aim:<\/jats:title>\n                    <jats:p>Friedreich\u2019s ataxia (FRDA) is a common cause of autosomal recessive cerebellar ataxia. The phenotype is dependent on the repeat size and duration of the disease. We aimed to study the clinical, electrophysiologic, and radiologic profiles in a large Indian cohort of genetically proven FRDA patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects and Methods:<\/jats:title>\n                    <jats:p>A retrospective cross-sectional, descriptive analysis of genetically proven FRDA patients was performed. A detailed review of all the hospital case records was done to analyze the clinical, radiologic, and electrophysiologic details.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 100 FRDA patients were selected for the analysis. Eighty-six patients had an age at onset between 5 and 25 years. Eight patients (8%) were classified as late-onset FRDA and six patients (6%) as early-onset FRDA. The median age at presentation was 19 years. The median age at onset was 14 years, and the median duration of illness was 4 years. All patients had gait ataxia as the initial symptom. Gait ataxia, loss of proprioception, and areflexia were seen in all patients. Dysarthria, nystagmus, amyotrophy, spasticity, extensor plantars, pes cavus, and scoliosis occurred in one-third of patients. Cardiomyopathy (18%) and diabetes (5%) were less common. Sensory polyneuropathy (87.5%) was the most common nerve conduction abnormality. Cortical somatosensory evoked responses were absent in all 43 tested patients (100%). Brainstem auditory evoked response test was done in 24 patients and it showed absent reactions in six patients (25%). Visual evoked potential was tested in 24 patients and it showed absent P100 responses in five patients (21%). Cerebellar and cord atrophy was seen on magnetic resonance imaging in 50% of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Most FRDA patients (86%) had an age at onset of less than 25 years, with typical symptoms of gait ataxia, areflexia, and loss of proprioception found in all patients. Dysarthria, nystagmus, amyotrophy, spasticity, extensor plantars, pes cavus, scoliosis, cardiomyopathy, and diabetes were not seen in all patients. Cerebellar atrophy can occur in FRDA patients. Knowledge regarding the clinical, radiologic, and electrophysiologic profile of FRDA will aid in proper phenotypic characterization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aian.aian_1001_23","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T08:00:33Z","timestamp":1712908833000},"page":"152-157","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Revisiting Friedreich\u2019s Ataxia: Phenotypic and Imaging Characteristics"],"prefix":"10.4103","volume":"27","author":[{"given":"Rohan","family":"Mahale","sequence":"first","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Purushottam","sequence":"additional","affiliation":[{"name":"Molecular Genetics Lab, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raviprakash","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandra","family":"Yelamanchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitish","family":"Kamble","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Holla","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod K.","family":"Pal","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Jain","sequence":"additional","affiliation":[{"name":"Molecular Genetics Lab, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1474-4422(14)70321-7","article-title":"Biological and clinical characteristics of the European Friedreich\u2019s Ataxia Consortium for Translational Studies (EFACTS) cohort: A cross-sectional analysis of baseline data","volume":"14","author":"Reetz","year":"2015","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"R2-20240828","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jnc.12215","article-title":"Prevalence gradients of Friedreich\u2019s ataxia and R1b haplotype in Europe co-localize, suggesting a common Palaeolithic origin in the Franco-Cantabrian ice age refuge","volume":"126","author":"Vankan","year":"2013","journal-title":"J Neurochem"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF01930976","article-title":"Ueber degenerative atrophie der spinalen hinterstr\u00e4nge","volume":"26","author":"Friedreich","year":"1863","journal-title":"Arch Pathol Anat Phys Klin Med"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/104.3.589","article-title":"Friedreich\u2019s ataxia: A clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features","volume":"104","author":"Harding","year":"1981","journal-title":"Brain"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","article-title":"Friedreich\u2019s ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion","volume":"271","author":"Campuzano","year":"1996","journal-title":"Science"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.37.1.1","article-title":"Friedreich ataxia: An overview","volume":"37","author":"Delatycki","year":"2000","journal-title":"J Med Genet"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s004399900201","article-title":"Genotype and phenotype analysis of Friedreich\u2019s ataxia compound heterozygous patients","volume":"106","author":"De Castro","year":"2000","journal-title":"Hum Genet"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1136\/jnnp.52.12.1398","article-title":"Late onset recessive ataxia with Friedreich\u2019s disease phenotype","volume":"52","author":"De Michele","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1001\/archneur.1993.00540080014006","article-title":"Late-onset Friedreich\u2019s ataxia. molecular genetics, clinical neurophysiology, and magnetic resonance imaging","volume":"50","author":"Klockgether","year":"1993","journal-title":"Arch Neurol"},{"issue":"Suppl 1","key":"R10-20240828","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jnc.12317","article-title":"Clinical features of Friedreich\u2019s ataxia: Classical and atypical phenotypes","volume":"126","author":"Parkinson","year":"2013","journal-title":"J Neurochem"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1525-1578(10)60523-5","article-title":"Triplet repeat primed PCR (TP PCR) in molecular diagnostic testing for Friedreich ataxia","volume":"6","author":"Ciotti","year":"2004","journal-title":"J Mol Diagn"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1017\/S0317167100025464","article-title":"Clinical description and roentgenologic evaluation of patients with Friedreich ataxia","volume":"3","author":"Geoffroy","year":"1976","journal-title":"Can J Neurol Sci"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0887-8994(03)00004-3","article-title":"Friedreich\u2019s ataxia","volume":"28","author":"Alper","year":"2003","journal-title":"Pediatr Neurol"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/hmg\/6.8.1261","article-title":"The Friedreich ataxia GAA triplet repeat: Premutation and normal alleles","volume":"6","author":"Montermini","year":"1997","journal-title":"Hum Mol Genet"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/bmb\/ldx034","article-title":"Friedreich\u2019s ataxia: Clinical features, pathogenesis and management","volume":"124","author":"Cook","year":"2017","journal-title":"Br Med Bull"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"fcad020","DOI":"10.1093\/braincomms\/fcad020","article-title":"Sequencing through hyperexpanded Friedreich\u2019s ataxia-GAA repeats by nanopore technology: Implications in genotype-phenotype correlation","volume":"5","author":"Uppili","year":"2023","journal-title":"Brain Commun"},{"key":"R17-20240828","first-page":"38","article-title":"Diagnosis and genetic counseling for Friedreich\u2019s Ataxia: A time for consideration of TP-PCR in an Indian Setup","volume":"17","author":"Muthuswamy","year":"2013","journal-title":"Hippokratia"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","article-title":"Clinical and genetic abnormalities in patients with Friedreich\u2019s ataxia","volume":"335","author":"D\u00fcrr","year":"1996","journal-title":"N Engl J Med"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/brain\/120.12.2131","article-title":"Friedreich\u2019s ataxia. Revision of the phenotype according to molecular genetics","volume":"120","author":"Sch\u00f6ls","year":"1997","journal-title":"Brain"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jns.2015.03.002","article-title":"Friedreich\u2019s Ataxia (FRDA) is an extremely rare cause of autosomal recessive ataxia in Chinese Han population","volume":"351","author":"Zeng","year":"2015","journal-title":"J Neurol Sci"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s12311-019-01055-z","article-title":"Frequency and genetic profile of compound heterozygous Friedreich\u2019s ataxia patients-the Brazilian Experience","volume":"18","author":"Peluzzo","year":"2019","journal-title":"Cerebellum"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"e1499","DOI":"10.1212\/WNL.0000000000200913","article-title":"Natural History of Friedreich Ataxia: Heterogeneity of neurologic progression and consequences for clinical trial design","volume":"99","author":"Rummey","year":"2022","journal-title":"Neurology"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1017\/S0317167100027773","article-title":"Evoked potential studies in Friedreich\u2019s ataxia and progressive early onset cerebellar ataxia","volume":"15","author":"Vanasse","year":"1988","journal-title":"Can J Neurol Sci"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1001\/archneur.62.12.1865","article-title":"Late-onset Friedreich ataxia: Phenotypic analysis, magnetic resonance imaging findings, and review of the literature","volume":"62","author":"Bhidayasiri","year":"2005","journal-title":"Arch Neurol"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.ejhg.5201257","article-title":"Extension of the mutation spectrum in Friedreich\u2019s ataxia: Detection of an exon deletion and novel missense mutations","volume":"12","author":"Z\u00fchlke","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejmg.2018.03.004","article-title":"Pitfalls in molecular diagnosis of Friedreich ataxia","volume":"61","author":"Barcia","year":"2018","journal-title":"Eur J Med Genet"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/archneurol.2011.834","article-title":"Exonic deletions of FXN and early-onset Friedreich ataxia","volume":"69","author":"Anheim","year":"2012","journal-title":"Arch Neurol"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/acn3.660","article-title":"Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia","volume":"6","author":"Lynch","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tips.2019.02.001","article-title":"Therapeutic prospects for Friedreich\u2019s ataxia","volume":"40","author":"Zhang","year":"2019","journal-title":"Trends Pharmacol Sci"}],"container-title":["Annals of Indian Academy of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/aian.aian_1001_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:48:34Z","timestamp":1787060914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aian.aian_1001_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/aian.aian_1001_23","relation":{},"ISSN":["0972-2327","1998-3549"],"issn-type":[{"value":"0972-2327","type":"print"},{"value":"1998-3549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"2023-11-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}